Varicella zoster virus vaccine

Details Varicella zoster virus vaccine Varicella zoster virus vaccine

C - Chemistry, Metallurgy

07

K

C07K 14/04 (2006.01) A61K 39/25 (2006.01) A61K 39/39 (2006.01) A61P 31/22 (2006.01) C12N 7/04 (2006.01)

Patent

CA 2600905

Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL are also claimed.

Utilisation d'une composition immunogène contenant VZV gE ou un des ses fragments immunogènes, et un adjuvant TH-1 afin de préparer un médicament servant à prévenir ou à améliorer le zona et/ou la névralgie post-herpétique. L'invention concerne également des compositions contenant un antigène tronqué de VZV gE et un adjuvant contenant QS21, cholestérol et 3D MPL.

Affiliated with

Also associated with

Rating

Varicella zoster virus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Varicella zoster virus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Varicella zoster virus vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1907174